UNSPSC 51191537: Dehydrocholic acid

This classification denotes a cholagogue or choleretic agent with the molecular formula C24H34O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier NH5000009I, chemically known as cholan-24-oic acid, 3,7,12-trioxo-, (5.beta.)- but generally known as dehydrocholic acid, which bears US NIH Compound Identifier 2975. European Medicines Agency schedules Dehydrocholic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06945MIG. The term DEHYDROCHOLIC ACID is an International Non-Proprietary Name.

UNSPSC 51191537 Dehydrocholic acid is a Commodity code that in recent state and local procurement activity covers specialized chemical and pharmaceutical products supplied to municipal and state agencies for treatment, healthcare, and operational compliance. Recent opportunities show state and local governments buying valve components for wastewater treatment infrastructure, parenteral nutrition and intravenous solutions for correctional healthcare, and sodium bisulfite for water pollution control — a scope considerably broader than the code's nominal name and spanning chemicals and equipment critical to regulated public health and environmental operations. Issuing bodies include state departments (the Washington State Department of Corrections), county governments (Broward County, Florida), and municipal utilities (the City of Meriden, Connecticut). The mix reflects procurement by agencies managing correctional facilities, wastewater treatment, and water pollution control rather than a single sector.

Geographic activity centers on Washington State, Florida, and Connecticut in the most recent opportunities, with the Washington DOC procurement spanning three operational regions across eight correctional facilities. Representative recent opportunities include Broward County's September 2026 Request for Information on DeZurik/APCO valves and repair services for wastewater compliance (response due September 29, 2026); the Washington State Department of Corrections' Request for Quote on parenteral products and services for eight facilities statewide (due October 7, 2026, with a pre-bid conference scheduled for September 23, 2026 and aspirational set-asides for small, minority-owned, women-owned, and veteran-owned businesses); and the City of Meriden's August 2026 invitation for bids on sodium bisulfite chemical supply for its Water Pollution Control Facility. The DOC procurement contemplates multiple awards across three regions with contract terms running through June 2030, while the Meriden and Broward opportunities represent single-source or limited-source supply relationships with fixed pricing requirements.